AGM/EGMApr 30, 2026, 04:26 PM
ALLR Sets Annual Meeting for June 26, 2026; Proposes Equity Plan Increase
AI Summary
Allarity Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 26, 2026. Stockholders of record as of May 7, 2026, are eligible to vote on several key proposals. These include the election of a Class I director, ratification of the independent auditor, an amendment to increase shares under the 2021 Equity Incentive Plan, and an advisory vote on executive compensation. Additionally, the company seeks approval for a common stock issuance exceeding Nasdaq limits and an amendment to limit officer liability.
Key Highlights
- Annual Meeting scheduled for Friday, June 26, 2026, at 10:00 a.m. Eastern Time, held virtually.
- Record date for stockholders entitled to vote is May 7, 2026.
- Proposes election of Jesper Hoiland as a Class I director to serve until the 2029 annual meeting.
- Seeks ratification of Wolf & Company, P.C. as independent registered public accounting firm for 2026.
- Proposes to increase 2021 Equity Incentive Plan shares from 1,521,990 to 2,021,990.
- Requests advisory approval for the compensation of named executive officers.
- Seeks approval for common stock issuance to Tumim Stone Capital LLC exceeding Nasdaq cap.
- Proposes amendment to Certificate of Incorporation to limit liability of certain officers.
Price Impact
More from ALLR